Ma W
Changhai hospital, Shanghai.
Zhonghua Shen Jing Jing Shen Ke Za Zhi. 1990 Jun;23(3):143-5, 189.
In this paper are described the method and results for the demonstration of the antibodies to citric acid extract of skeletal muscle (CAE-ab) in the sera from myasthenia gravis (MG) patients with or without thymoma, in patients with other diseases and in healthy controls by an indirect hemagglutination assay (IHA), were described. The CAE-ab titers were positive in 15 (71.43%) of the 21 MG patients with thymoma, the antibody titers ranging from 1:16 to 1:512. In the 35 MG patients without thymoma, as well as in the 32 healthy controls and 22 patients with other diseases, the antibody titers were all negative A statistically significant difference was found between the CAE-ab titers in the group of MG patients with thymoma and those in the other three groups. It was considered that IHA for the purpose of demonstrating CAE-ab could serve as a supplementary diagnostic method for early detection of thymoma in MG patients at an early stage.
本文描述了通过间接血凝试验(IHA)检测重症肌无力(MG)伴或不伴胸腺瘤患者、其他疾病患者及健康对照血清中抗骨骼肌柠檬酸提取物抗体(CAE-ab)的方法及结果。21例伴胸腺瘤的MG患者中,15例(71.43%)的CAE-ab滴度呈阳性,抗体滴度范围为1:16至1:512。35例不伴胸腺瘤的MG患者、32例健康对照及22例其他疾病患者的抗体滴度均为阴性。伴胸腺瘤的MG患者组与其他三组的CAE-ab滴度之间存在统计学显著差异。认为用于检测CAE-ab的IHA可作为早期检测MG患者胸腺瘤的辅助诊断方法。